Thoracic organ transplantation

被引:50
作者
Pierson, RN [1 ]
Barr, ML
McCullough, KR
Egan, T
Garrity, E
Jessup, M
Murray, S
机构
[1] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA
[2] VA, Baltimore, MD USA
[3] Univ So Calif, Los Angeles, CA USA
[4] SRTR URREA, Ann Arbor, MI USA
[5] Univ N Carolina, Chapel Hill, NC USA
[6] Loyola Univ Chicago, Chicago, IL USA
[7] Univ Penn, Philadelphia, PA 19104 USA
[8] Univ Michigan, SRTR, Ann Arbor, MI 48109 USA
关键词
allocation policy; deceased donors; graft survival; heart transplantation; heart-lung transplantation; living donors; lung transplantation; organ donation; patient survival; SRTR; waiting list;
D O I
10.1111/j.1600-6135.2004.00401.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
This article presents an overview of factors associated with thoracic transplantation outcomes over the past decade and provides valuable information regarding the heart, lung, and heart-lung waiting lists and thoracic organ transplant recipients. Waiting list and post-transplant information is used to assess the importance of patient demographics, risk factors, and primary cardiopulmonary disease on outcomes. The time that the typical listed patient has been waiting for a heart, lung, or heart-lung transplant has markedly increased over the past decade, while the number of transplants performed has declined slightly and survival after transplant has plateaued. Waiting list mortality, however, appears to be declining for each organ and for most diseases and high-severity subgroups, perhaps in response to recent changes in organ allocation algorithms. Based on perceived inequity in organ access and in response to a mandate from Health Resources and Services Administration, the lung transplant community is developing a lung allocation system designed to minimize deaths on the waiting list while maximizing the benefit of transplant by incorporating post-transplant survival and quality of life into the algorithm. Areas where improved data collection could inform evolving organ allocation and candidate selection policies are emphasized.
引用
收藏
页码:93 / 105
页数:13
相关论文
共 28 条
[1]   Intrathoracic organ transplantation in the United Kingdom 1995-99: results from the UK cardiothoracic transplant audit [J].
Anyanwu, AC ;
Rogers, CA ;
Murday, AJ .
HEART, 2002, 87 (05) :449-454
[2]   Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation [J].
Arcasoy, SM ;
Christie, JD ;
Pochettino, A ;
Rosengard, BR ;
Blumenthal, NP ;
Bavaria, JE ;
Kotloff, RM .
CHEST, 2001, 120 (03) :873-880
[3]  
Aris R, 1998, AM J RESP CRIT CARE, V158, P335
[4]   Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients [J].
Augarten, A ;
Akons, H ;
Aviram, M ;
Bentur, L ;
Blau, H ;
Picard, E ;
Rivlin, J ;
Miller, MS ;
Katznelson, D ;
Szeinberg, A ;
Shmilovich, H ;
Paret, G ;
Laufer, J ;
Yahav, Y .
PEDIATRIC TRANSPLANTATION, 2001, 5 (05) :339-342
[5]   The Registry of the International Society for Heart and Lung Transplantation: Fifth official pediatric report 2001 to 2002 [J].
Boucek, MM ;
Edwards, LB ;
Keck, BM ;
Trulock, EP ;
Taylor, DO ;
Mohacsi, PJ ;
Hertz, MI .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (08) :827-840
[6]   What is the optimal medical management of ischemic heart failure? [J].
Cleland, JGF ;
Alamgir, F ;
Nikitin, NP ;
Clark, AL ;
Norell, M .
PROGRESS IN CARDIOVASCULAR DISEASES, 2001, 43 (05) :433-455
[7]   Transplant data: sources, collection, and caveats [J].
Dickinson, DM ;
Bryant, PC ;
Williams, MC ;
Levine, GN ;
Li, SQ ;
Welch, JC ;
Keck, BM ;
Webb, RL .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 :13-26
[8]  
Egan T., 2003, Journal of Heart and Lung Transplantation, V22, pS147, DOI 10.1016/S1053-2498(02)00921-X
[9]  
Egan T., 2003, Journal of Heart and Lung Transplantation, V22, pS146, DOI 10.1016/S1053-2498(02)00920-8
[10]  
Egan T. M., 2002, Journal of Heart and Lung Transplantation, V21, P154, DOI 10.1016/S1053-2498(01)00709-4